<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02376205</url>
  </required_header>
  <id_info>
    <org_study_id>JPNI-4</org_study_id>
    <nct_id>NCT02376205</nct_id>
  </id_info>
  <brief_title>Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery</brief_title>
  <official_title>The Effectiveness of Postoperative Local Retropharyngeal Space Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Justin Parker Neurological Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Justin Parker Neurological Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to analyze the effects of local anesthetic application
      into the retropharyngeal space and its ability to reduce dysphagia symptoms and/or occurrence
      rates in patients undergoing anterior cervical discectomy and fusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients will be randomly assigned into one of the two groups to receive either
      bupivacaine hydrochloride 0.5% solution if they are randomized to the treatment group or 0.9%
      NaCl solution if they are randomized to the control group. These solutions will be poured
      into the retropharyngeal space intraoperatively before wound closure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">March 11, 2019</completion_date>
  <primary_completion_date type="Actual">March 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in dysphagia scores</measure>
    <time_frame>3 months</time_frame>
    <description>Swallowing-Quality of Life Questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Dysphagia</condition>
  <arm_group>
    <arm_group_label>bupivacaine hydrochloride 0.5% solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bupivacaine hydrochloride 0.5% 10 mL solution poured into the retropharyngeal space intraoperatively before wound closure during anterior cervical discectomy and fusion procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.9% NaCl solution</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% NaCl 10 mL solution poured into the retropharyngeal space intraoperatively before wound closureduring anterior cervical discectomy and fusion procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine hydrochloride 0.5% solution</intervention_name>
    <description>10mL will be poured into the retropharyngeal space intraoperatively during anterior cervical discectomy and fusion procedure</description>
    <arm_group_label>bupivacaine hydrochloride 0.5% solution</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% NaCl solution</intervention_name>
    <description>10mL will be poured into the retropharyngeal space intraoperatively during anterior cervical discectomy and fusion procedure</description>
    <arm_group_label>0.9% NaCl solution</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 y.o.

          -  Patients undergoing one- or two-level anterior cervical discectomy and fusion surgery
             for radiculopathy or myelopathy symptoms

          -  Patients are wiling and able to sign informed consent and complete questionnaires

        Exclusion Criteria:

          -  More than 2-level ACDF surgeries

          -  Previous cervical spine surgery

          -  Surgeries for trauma, infection or tumor

          -  Known hypersensitivity reactions to bupivacaine hydrochloride or other amino-amide
             anesthetics (e.g. lidocaine)

          -  Known history of swallowing issues (e.g. dysphagia, odynophagia)

          -  Pregnant or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Mason, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boulder Neurosurgical Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boulder Neurosurgical Associates</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2015</study_first_submitted>
  <study_first_submitted_qc>February 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anterior Cervical Discectomy and Fusion</keyword>
  <keyword>Dysphagia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

